dementia-congress-2018-scientifictracks

14 / 14

Page 29
Notes:
conferenceseries.com
Volume 8 Journal of Alzheimers Disease & Parkinsonism Dementia Congress 2018
September 17-18, 2018
September 17-18, 2018 Singapore
12th World Congress on
Advances and Innovations in Dementia
Artemissia-Phoebe Nifli, J Alzheimers Dis Parkinsonism 2018, Volume 8
DOI: 10.4172/2161-0460-C5-048
Meaningful measures of metabolic and appetite perturbations in dementia prevention, diagnosis and
care
Artemissia-Phoebe Nifli
University of Crete, Greece
The increasing prevalence of dementia worldwide and the development of diagnostic tools paved the way for amore thorough
investigation of the course of the disease. Due to the same reasons, the transition to the final stages has been delayed for
a great fraction of subjects, while the latent character of cognitive impairment has been established, as amyloid beta and tau
deposits may accumulate for decades before the onset of symptoms. Therefore, it was speculated that other factors could incite
or precipitate the progression of dementia. Recent findings support the interference of metabolic impairment, yet, it is not
clear how the differentiation of metabolic markers in middle age or early stage would later promote cognitive deterioration.
On the other hand, weight and appetite disturbances are vast and easily quantifiable late in the trajectory of the disease. It
seems possible for the non-cognitive signs to synchronize with cognitive impairment, and for hormones, oxidative capacity,
mal-absorption and muscle wasting to synchronize with the ongoing depositions in the mature brain. Although it is premature
to incorporate all these changes to decision-making, the cross-talk among chemosensory experience, food preferences and
nutritional habits, glucose and lipid metabolism and peripheral and central neurodegeneration indicates the need for a
comprehensive approach. It is also encouraging that even in late-stage dementia patients, the limited pharmacotherapy, as
well as the non-pharmacological interventions may substantially improve metabolic and appetite perturbations, in spite of
cognitive decline.
Biography
Artemissia-Phoebe Nifli is Specialized in Neurosciences and Experimental Endocrinology at the Faculty of Medicine, University of Crete and worked as a
Postdoctoral Fellow at Harvard University. Besides her intermittent academic duties, she is a Principal Investigator at TRC-Thessaly, studying the biochemical and
behavioral denominators of human nutrition. She has presented her work in 72 conferences and published more than 26 papers in peer-reviewed journals. She is
also Member of the Reviewer Board of several acclaimed scientific journals, while she is a long-time Member of Alzheimer Hellas.